| Ytd | 0.52% | |
| 1y | -14.47% |
| Open | 28.90 | Prev Close | 29.04 | Low | 28.78 | High | 30.39 | Mkt Cap | 145.36M |
| Vol | 0.00 | Avg Vol | 135.97K | EPS | -13.95 | P/E | -2.08 | Forward P/E | -2.19 |
| Beta | 0.44 | Short Ratio | 6.45 | Inst. Own | 95.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 22.88 | 200-d Avg | 11.99 | 1yr Est | 6.50 |
MRSN News
Cwm LLC lowered its position in shares of Mersana Therapeutics, Inc. (NASDAQ: MRSN) by 96.5% in the
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
BALA CYNWYD, Pa. , Dec. 23, 2025 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the foll
MILWAUKEE , Dec. 16, 2025 /PRNewswire/ -- The Ademi Firm continues to investigate Mersana (NASDAQ: M
NEW YORK and NEW ORLEANS , Dec. 12, 2025 /PRNewswire/ -- Former Attorney General of Louisiana Charle
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is invest
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- We wish you a Happy Thanksgiving and Class Action Attorn
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Mersana Therapeutics, Inc. (MRSN) came out with a quarterly loss of $1.51 per share versus the Zacks
NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde an
Mersana Therapeutics, Inc. ( MRSN ) M&A Call November 13, 2025 8:00 AM EST Company Participants Joey
MILWAUKEE , Nov. 13, 2025 /PRNewswire/ -- The Ademi Firm is investigating Mersana (NASDAQ: MRSN) for
Day One Biopharmaceuticals (NASDAQ: DAWN) on Thursday agreed to acquire Mersana Therapeutics Inc. (N
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Agreement with Day One Biopharmaceuticals provides for upfront consideration of $25.00 per share in
CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a cli
The average of price targets set by Wall Street analysts indicates a potential upside of 248.8% in M
Mersana Therapeutics, Inc. (NASDAQ:MRSN ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM E
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
On Wednesday, 807 companies reached new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday af
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018
Stocks Which Set New 52-Week Low Friday, October 26th
Stocks Which Set New 52-Week Low Yesterday, October 11th
Stocks Which Set New 52-Week Low Yesterday, October 10th